Busy wedding week underway over here, but make sure to check out my amazing ASN colleagues and their work/contributions. Stop by and say hello at @IDWeekmtg #IDWeek2024

We are hiring with @OSUWexMed for another ID pharmacist! 🧫🦠 Join us in ASP and ID consult services, including care provided to patients with a history of malignancy and solid organ transplant. Collaborate with amazing pharmacists in teaching and research! More info below ⬇️

“I like infectious disease” ⬇️ “Oh shit student loans” ⬇️ “I like cardiology” ⬇️ Super bacteria destroys human race. Everybody dies with clean coronary arteries.

congratulations @emilylheil and team for this beautiful work on clindamycin vs linezolid for severe GAS infections!! LOVE to see it 🤩🤩 https://t.co/uUOoLojQC4

🔥 JUST PUBLISHED 🔥 Clinical Practice Guideline by the Pediatric Infectious Diseases Society (@PIDSociety) and the Infectious Diseases Society of America (@IDSAInfo): 2023 Guideline on Diagnosis and Management of Acute Bacterial Arthritis in Pediatrics https://t.co/tzikqTnrBk

The biggest thing in #Crypto in years?! A game changer in the treatment of severe fungal infections! 🔥EnACT P2 RCT🔥 Oral ampho B with 5FC demonstrated similar survival and less toxicity than IV ampho B and 5FC for treatment of cryptococcal meningitis

Today we approved a new drug to prevent Respiratory Syncytial Virus (RSV) disease in: - infants born during or entering their first RSV season - children up to 24 months who remain vulnerable to severe RSV through their second RSV season Learn more: https://t.co/0PGt9XR230

Infectious disease visits a fish market

Who wants to join the most fantastic antimicrobial stewardship team?? Come join me and my fantastic stewardship team ... https://t.co/3sSP2ey4XP

Development of 8‐Hour Urine Collections and an Augmented Renal Clearance Dosing Program ⁦@KeatonSmetana⁩ ⁦@lynnwardlow⁩ ⁦@cvhmurphy⁩ ⁦@osu_pharmacy⁩ ⁦@OSUWexMed⁩

Check out Carrie Kovacik’s awesome residency project evaluating first-dose infusion reactions in #OPAT patients! @UVARxResidency @UVA_ID https://t.co/pplsf2AWSM

Our very own Amy Mathers is currently testifying to Congress about antimicrobial resistance!

🚨 WE’RE HIRING! 🚨 💊 OPAT and HIV management in Duke University Hospital’s ID Clinic 👫 join a team of two wonderful clinical pharmacists in the space 🩺 enjoy interdisciplinary teamwork with the esteemed members of @DukeAdultID 🔗 to apply: https://t.co/S5kmrtes0V

Abx-induced neutropenia in OPAT pts. Very nice to have comparative incidences for this! Top 3: vanco, ceftriaxone, and cloxacillin Also interesting, 9/9 beta-lactam induced neutropenia who switched to different BL w/ unique sidechain resolved Link: https://t.co/B5LmjBbjHq

Developed by #Sanofi and #AstraZeneca, the single-dose long-acting antibody was designed to help protect all infants from birth through their first #RSV season. #Nirsevimab #IDtwitter #MedTwitter https://t.co/BEtlfDT4VN

🆕⚡⚡@CIDJournal @pranita_tamma @TheIDApprentice @padstamundo @romneyintn Breaking Down the Breakpoints: Rationale for the 2022 @CLSI_LabNews Revised Piperacillin-Tazobactam Breakpoints Against Enterobacterales #IDTwitter https://t.co/d6PepEWmKL

𝐂𝐇𝐀𝐌𝐏𝐈𝐎𝐍𝐒𝐇𝐈𝐏 𝐁𝐎𝐔𝐍𝐃. #CarolinaFamily | #MarchMadness

𝐇𝐄𝐄𝐋𝐒 𝐖𝐈𝐍!!! #CarolinaFamily | @WellsFargo

Check out our ID resident's @_MarissaRees awesome work demonstrating the benefits of an individualized AUC-based trough range for patients being discharged on vancomycin OPAT. https://t.co/KJboo8s9Y9 @DustinRCarr @CessnaPharmD @carleyb1016